These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Integration of Engineered Delivery with the Pharmacokinetics of Medical Candidates via Physiology-Based Pharmacokinetics. Yang Y; Zhang X Methods Mol Biol; 2022; 2486():57-69. PubMed ID: 35437718 [TBL] [Abstract][Full Text] [Related]
5. In silico approaches for predicting ADME properties of drugs. Yamashita F; Hashida M Drug Metab Pharmacokinet; 2004 Oct; 19(5):327-38. PubMed ID: 15548844 [TBL] [Abstract][Full Text] [Related]
6. In Silico Tools and Software to Predict ADMET of New Drug Candidates. Kar S; Roy K; Leszczynski J Methods Mol Biol; 2022; 2425():85-115. PubMed ID: 35188629 [TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Singh SS Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106 [TBL] [Abstract][Full Text] [Related]
8. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools. Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068 [TBL] [Abstract][Full Text] [Related]
9. truPK -- human pharmacokinetic models for quantitative ADME prediction. Subramanian K Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic properties and in silico ADME modeling in drug discovery. Honório KM; Moda TL; Andricopulo AD Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542 [TBL] [Abstract][Full Text] [Related]
11. Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles. Li M; Zou P; Tyner K; Lee S AAPS J; 2017 Jan; 19(1):26-42. PubMed ID: 27834047 [TBL] [Abstract][Full Text] [Related]
12. PBPK models for the prediction of in vivo performance of oral dosage forms. Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672 [TBL] [Abstract][Full Text] [Related]
14. Improving early drug discovery through ADME modelling: an overview. Wishart DS Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426 [TBL] [Abstract][Full Text] [Related]
15. Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection. Balani SK; Miwa GT; Gan LS; Wu JT; Lee FW Curr Top Med Chem; 2005; 5(11):1033-8. PubMed ID: 16181128 [TBL] [Abstract][Full Text] [Related]
16. The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery. Lin J; Sahakian DC; de Morais SM; Xu JJ; Polzer RJ; Winter SM Curr Top Med Chem; 2003; 3(10):1125-54. PubMed ID: 12769713 [TBL] [Abstract][Full Text] [Related]
17. High-throughput and in silico techniques in drug metabolism and pharmacokinetics. van de Waterbeemd H Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671 [TBL] [Abstract][Full Text] [Related]
18. Can the Internet help to meet the challenges in ADME and e-ADME? Van de Waterbeemd H; De Groot M SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380 [TBL] [Abstract][Full Text] [Related]
19. Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs? Bouzom F; Ball K; Perdaems N; Walther B Biopharm Drug Dispos; 2012 Mar; 33(2):55-71. PubMed ID: 22228149 [TBL] [Abstract][Full Text] [Related]
20. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods. Tsaioun K; Blaauboer BJ; Hartung T ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]